Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 281, Issue 17, Pages 11541-11552Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M511214200
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI051454] Funding Source: Medline
- NIDDK NIH HHS [R01 DK063167-05, DK063167, R01 DK063167-04, R01 DK063167-03, R01 DK063167-02, R01 DK063167-01A2, R01 DK063167] Funding Source: Medline
Ask authors/readers for more resources
Inflammatory cytokines such as interleukin-1 and tumor necrosis factor-alpha modulate a transcription factor cascade in the liver to induce and sustain an acute and systemic defense against foreign entities. The transcription factors involved include NF-kappa B, STAT, and CCAAT/enhancer-binding protein ( C/EBP). Whether the NFAT group of transcription factors ( which was first characterized as playing an important role in cytokine gene expression in the adaptive response in immune cells) participates in the acute- phase response in hepatocytes is not known. Here, we have investigated whether NFAT is part of the transcription factor cascade in hepatocytes during inflammatory stress. We report that interleukin-1 or tumor necrosis factor-alpha increases expression of and activates NFATc2. C/EBP-mediated NFATc2 induction is temporally required for expression of type IIA secretory phospholipase A(2). NFATc2 is also required for expression of phospholipase D-1 and the calcium-binding protein S100A3. Thus, a C/EBP-NFATc2 transcription factor cascade provides an additional means to modulate the acute-phase response upon stimulation with inflammatory cytokines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available